Clinical trial

A Study Comparing the Effectiveness and Safety of Extended-release Tramadol…

NCT00347724 · Bausch Health Americas, Inc., Industry · Completed

Key facts

NCT number NCT00347724
Title A Study Comparing the Effectiveness and Safety of Extended-release Tramadol Versus Placebo in the Treatment of Chronic Low Back Pain
Official title Double-blind, Randomized, Placebo-controlled, Parallel Group Comparison of the Efficacy and Safety of Extended Release Tramadol (Tramadol ER) 300 mg and 200 mg to Placebo in the Treatment of Chronic Low Back Pain
Lead sponsor Bausch Health Americas, Inc., Industry
Status Completed
Phase Phase 3
Study type Interventional
Conditions Chronic Pain
Intervention type Drug
Interventions Tramadol HCl ER
Enrollment 600
Start date Nov 1, 2000
Completion Nov 1, 2001
First posted Jul 4, 2006
Last update posted Jun 21, 2012

At a glance

  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies